NICE has developed a Medtech Innovation Briefing (MIB) on Medtech innovation briefing The NxStage System One NX1000-1 home haemodialysis device for renal replacement therapy in chronic kidney disease

The NxStage System One is a haemodialysis system for renal replacement therapy to be used at home or while travelling. The system can run from standard home electricity and water supplies, and is smaller than conventional home haemodialysis systems.

Their purpose is to provide objective information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals. By making this information available, NICE helps to avoid the need for NHS organisations to produce similar information for local use.

Medtech Innovation Briefings are not NICE guidance. They differ in format, contain no judgement on the value of the technology and do not constitute a guidance recommendation.

MIBs are commissioned by NHS England and produced in support of the NHS 5 Year Forward View, specifically as one of a number of steps which will accelerate innovation in new treatments and diagnostics.